IRIS
DE SARRO, Angelina
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.689
EU - Europa 2.092
AS - Asia 1.909
SA - Sud America 726
AF - Africa 66
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 4
Totale 8.490
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.631
SG - Singapore 808
BR - Brasile 646
SE - Svezia 524
CN - Cina 516
IE - Irlanda 509
UA - Ucraina 343
HK - Hong Kong 229
DE - Germania 223
VN - Vietnam 164
GB - Regno Unito 135
FI - Finlandia 121
RU - Federazione Russa 95
IN - India 59
IT - Italia 35
AR - Argentina 28
CA - Canada 23
MX - Messico 22
ZA - Sudafrica 20
AT - Austria 19
BD - Bangladesh 17
BE - Belgio 17
TR - Turchia 16
MA - Marocco 15
EC - Ecuador 14
JP - Giappone 13
PL - Polonia 13
JO - Giordania 11
UZ - Uzbekistan 11
PK - Pakistan 10
AE - Emirati Arabi Uniti 9
FR - Francia 9
NL - Olanda 9
CL - Cile 8
CZ - Repubblica Ceca 8
ES - Italia 8
IQ - Iraq 8
EG - Egitto 7
PE - Perù 7
VE - Venezuela 7
CO - Colombia 5
PY - Paraguay 5
RS - Serbia 5
UY - Uruguay 5
AZ - Azerbaigian 4
IL - Israele 4
IR - Iran 4
KE - Kenya 4
MN - Mongolia 4
PA - Panama 4
TN - Tunisia 4
CI - Costa d'Avorio 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
NG - Nigeria 3
NP - Nepal 3
OM - Oman 3
SN - Senegal 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AL - Albania 2
AU - Australia 2
BG - Bulgaria 2
BW - Botswana 2
CR - Costa Rica 2
EE - Estonia 2
EU - Europa 2
GE - Georgia 2
GR - Grecia 2
HU - Ungheria 2
JM - Giamaica 2
KR - Corea 2
LB - Libano 2
NZ - Nuova Zelanda 2
PS - Palestinian Territory 2
AM - Armenia 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
BN - Brunei Darussalam 1
BO - Bolivia 1
BY - Bielorussia 1
GT - Guatemala 1
HR - Croazia 1
ID - Indonesia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LI - Liechtenstein 1
LT - Lituania 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MY - Malesia 1
PH - Filippine 1
RO - Romania 1
SA - Arabia Saudita 1
SK - Slovacchia (Repubblica Slovacca) 1
TT - Trinidad e Tobago 1
Totale 8.490
Salva come PNG Salva come JPEG
Città #
Jacksonville 670
Dublin 509
Dallas 487
Chandler 425
Singapore 413
Ashburn 382
Nyköping 263
Beijing 258
Hong Kong 227
Dong Ket 125
Princeton 105
Cambridge 104
Boardman 84
Los Angeles 79
Des Moines 78
Medford 76
Ann Arbor 65
The Dalles 56
Dearborn 51
Buffalo 50
São Paulo 39
Woodbridge 37
Pune 29
Wilmington 25
Belo Horizonte 21
Jinan 21
New York 20
Rio de Janeiro 20
Lancaster 19
Redondo Beach 19
Ho Chi Minh City 18
Shenyang 18
Tianjin 18
Vienna 18
Brussels 17
Moscow 16
Hyderabad 14
Seattle 14
London 13
Auburn Hills 12
Curitiba 11
Hangzhou 11
Hebei 11
Helsinki 11
Munich 11
Warsaw 11
Brooklyn 10
Houston 10
Johannesburg 10
Montreal 10
Ningbo 10
Porto Alegre 10
Saint Petersburg 10
San Mateo 10
Stockholm 10
Washington 10
Amman 9
Amsterdam 9
Campinas 9
Monmouth Junction 9
Poplar 9
Taizhou 9
Tashkent 9
Zhengzhou 9
Morikitamachi 8
Norwalk 8
San Francisco 8
Brasília 7
Casablanca 7
Chicago 7
Contagem 7
Frankfurt am Main 7
Milan 7
Phoenix 7
Salvador 7
Turku 7
Ankara 6
Augusta 6
Cape Town 6
Changsha 6
Edinburgh 6
Hanoi 6
Juiz de Fora 6
Lima 6
Mexico City 6
Quito 6
Santa Clara 6
Atlanta 5
Belgrade 5
Boston 5
Brno 5
Campo Grande 5
Denver 5
Duque de Caxias 5
Fuzhou 5
Goiânia 5
Guangzhou 5
Hortolândia 5
Leawood 5
Montevideo 5
Totale 5.371
Salva come PNG Salva come JPEG
Nome #
1-aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: Novel AMPA receptor antagonists 231
1,4-benzodiazepine derivatives as anticonvulsant agents in DBA/2 mice 206
5-lipoxygenase knockout mice exhibit a resistance to acute pancreatitis induced by cerulein 178
5-AMINOISOQUINOLINONE REDUCES COLON INJURY BY EXPERIMENTAL COLITIS 176
Absence of endogenous interleukin-6 enhances the inflammatory response during acute pancreatitis induced by cerulein in mice 152
3,5-dihydro-4H-2,3-benzodiazepine-4-thiones: A new class of AMPA receptor antagonists 150
7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists 140
Anticonvulsant activity of azirino[1,2-d][1,4]benzodiazepines and related 1,4-benzodiazepines in mice 137
5H-[1,2,4]Oxadiazolo[5,4-d][1,5]benzothiazepines as anticonvulsant agents in DBA/2 mice. 135
Amoxicillin and amoxicillin plus clavulanate: a safety review 126
Activity and postantibiotic effect of marbofloxacin, enrofloxacin, difloxacin and ciprofloxacin against feline Bordetella bronchiseptica isolates 120
Activity of nine fluoroquinolones against strains of Bordetella bronchiseptica 112
Anticonvulsant activity and plasma level of 2,3-benzodiazepin- 4-ones (CFMs) in genetically epilepsy-prone rats 111
Azirino[1,2-d][1,4]benzodiazepine derivatives and related 1,4- benzodiazepines as anticonvulsant agents in DBA/2 mice 111
Focus: Linguistic, cognitive, and computational perspectives 109
Beneficial effects of GPI 6150, an inhibitor of poly(ADP-ribose) polymerase in a rat model of splanchnic artery occlusion and reperfusion 102
Geometric models in classical thermomechanics of continua with applications to irreversible phenomena 102
Attenuation in the evolution of experimental spinal cord trauma by treatment with melatonin 101
Bactericidal activity of lansoprazole and three macrolides against Helicobacter pylori strains tested by the time-kill kinetic method 101
7-nitroindazole potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 100
New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance 100
Amoxicillin and amoxicillin plus clavulanate: a safety review. 99
ANTICONVULSANT ACTIVITY OF PYRROLO[1',2'-1,2]IMIDAZO[4,5- B]PYRIDINES, PYRROLO[2',1'-2,3]IMIDAZO[4,5-C] PYRIDINES AND PYRROLO[2,1-F]PURINES IN DBA/2 MICE 96
Role of induced nitric oxide in the initiation of the inflammatory response after postischemic injury 95
Novel potent AMPA/kainate receptor antagonists: Synthesis and anticonvulsant activity of a series of 2-[(4- alkylsemicarbazono)-(4-aminophenyl)methyl]-4,5- methylenedioxyphenylacetic acid alkyl esters 95
Adverse reactions to fluoroquinolones. An overview on mechanistic aspects 95
Effects of n-acetylcysteine in a rat model of ischemia and reperfusion injury 94
Protective effects of melatonin in ischemic brain injury 92
Synthesis and pharmacological evaluation of 4-aryl-6,7- dimethoxyphthalazines as anticonvulsant agents 90
BENEFICIAL EFFECTS OF 5-AMINOISOQUINOLINONE, A NOVEL, POTENT, WATER-SOLUBLE, INHIBITOR OF POLY(ADP-RIBOSE)POLYMERASE, IN A RAT MODEL OF SPLANCHNIC ARTERY OCCLUSION AND REPERFUSION 90
Synthesis and anticonvulsant activity of novel and potent 1- aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3- benzodiazepin-4-ones 89
Synthesis and anticonvulsant activity of novel and potent 6,7- methylenedioxyphthalazin-1(2H)-ones 88
Effects of tempol, a membrane-permeable radical scavenger, in a gerbil model of brain injury 87
Beneficial effects of n-acetylcysteine on ischaemic brain injury 87
NOVEL ANNELATED 1,4-BENZODIAZEPINES AND 1,5-BENZODIAZEPINES 86
Amelioration of joint disease in a rat model of collagen- induced arthritis by M40403, a superoxide dismutase mimetic 85
Comparative anticonvulsant activity of some 2,3-benzodiazepine derivatives in rodents 84
Synthesis and pharmacological properties of new 3- ethoxycarbonyl-11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepines 83
Synthesis and anticonvulsant activity of novel and potent 2,3- benzodiazepine AMPA/kainate receptor antagonists 82
Synthesis and anticonvulsant activity of triazolo[4,5-c][2,3]benzodiazepines 81
Susceptibility to audiogenic seizure and neurotransmitter amino acid levels in different brain areas of IL-6-deficient mice 81
Regulation of prostaglandin generation in carrageenan-induced pleurisy by inducible nitric oxide synthase in knockout mice 81
Role of tight junction derangement in the endothelial dysfunction elicited by exogenous and endogenous peroxynitrite and poly(ADP-ribose) synthetase 80
Influence of carbenoxolone on the anticonvulsant efficacy of conventional antiepileptic drugs against audiogenic seizures in DBA/2 mice 77
Endogenous interleukin-6 enhances the renal injury, dysfunction, and inflammation caused by ischemia/reperfusion 75
Synthesis and anticonvulsant activity of new 11H-triazolo[4,5- c] [2,3]benzodiazepines 75
New and investigational antimicrobials for the treatment of severe skin infections 75
Protective effects of n-acetylcysteine on lung injury and red blood cell modification induced by carrageenan in the rat 75
Beneficial effects of melatonin in a rat model of splanchnic artery occlusion and reperfusion 74
The tyrosine kinase inhibitor tyrphostin AG126 reduces the development of acute and chronic inflammation 74
Influence of some beta-adrenoceptor antagonists on the anticonvulsant potency of antiepileptic drugs against audiogenic seizures in DBA/2 mice 74
Influence of D-cycloserine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice 74
GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice 74
Synthesis and evaluation of pharmacological properties of novel annelated 2,3-benzodiazepine derivatives 73
Linear hyperbolic systems of order-k in bounded and unbounded sets. Stability of complete controllability 73
Benzodiazepine receptor affinities, behavioral, and anticonvulsant activity of 2-aryl-2,5-dihydropyridazino[4,3- b]indol-3(3H)-ones in mice 73
ERYTHROPOIETIN REDUCES THE DEVELOPMENT OF EXPERIMENTAL INFLAMMATORY BOWEL DISEASE 73
Effect of N-acetylcysteine on gentamicin-mediated nephropathy in rats 72
RELATIONSHIP BETWEEN STRUCTURE AND CONVULSANT PROPERTIES OF SOME BETA-LACTAM ANTIBIOTICS FOLLOWING INTRACEREBROVENTRICULAR MICROINJECTION IN RATS 71
Quinolones potentiate cefazolin-induced seizures in DBA/2 mice. 70
Beneficial effects of GW274150 treatment on the development of experimental colitis induced by dinitrobenzene sulfonic acid. 69
Role of interleukin-6 in a non septic shock model induced by zymosan 69
Structure-activity relationships in thienodiazepine and benzodiazepine derivatives. 69
Effect of melatonin on cellular energy depletion mediated by peroxynitrite and poly (ADP-ribose) synthetase activation in an acute model of inflammation 69
Green tea polyphenol extract attenuates colon injury induced by experimental colitis 68
New and investigational triazole agents for the treatment of invasive fungal infections 68
Effects of melatonin on ischemic brain injury 68
SYNTHESIS AND ANTICONVULSANT PROPERTIES OF 3-(1,3,4-THIADIAZOL- 2-YL)THIAZOLIDIN-4-ONES 67
Topiramate potentiates the antiseizure activity of some anticonvulsants in DBA/2 mice 66
Role of IL-6 in the pleurisy and lung injury caused by carrageenan 66
Influence of retigabine on the anticonvulsant activity of some antiepileptic drugs against audiogenic seizures in DBA/2 mice 65
Inducible nitric oxide synthase - Knockout mice exhibit resistance to pleurisy and lung injury caused by carrageenan 65
Protective effects of Celecoxib on lung injury and red blood cells modification induced by carrageenan in the rat 65
Cloricromene, a coumarine derivative, protects against collagen-induced arthritis in Lewis rats 64
Effects of compounds acting on GABA(B) receptors in the pentylenetetrazole kindling model of epilepsy in mice 64
Synthesis and anticonvulsant activity of new 2,3- benzodiazepines as AMPA receptor antagonists 64
Comparative anticonvulsant activity of N-acetyl-1-aryl-6,7-dimethoxy-1,2,3,4-tetrahydroisoquinoline derivatives in rodents 63
Synthesis and anticonvulsant properties of 2,3,3a,4-tetrahydro- 1H-pyrrolo[1,2-a]benzimidazol-1-one derivatives 63
Convulsant effects of some xanthine: Derivatives in genetically epilepsy-prone rats 63
NMDA and AMPA/kainate receptors are involved in the anticonvulsant activity of riluzole in DBA/2 mice 62
Effects of some excitatory amino acid antagonists and drugs enhancing gamma-aminobutyric acid neurotransmission on pefloxacin-induced seizures in DBA/2 mice 62
Tolerance and pharmacokinetics of ciprofloxacin in the chick. Preliminary experience in subjects of pediatric age with urinary tract infections (UTI) 62
Enhanced susceptibility of pentylenetetrazole kindled mice to quinolone effects 61
WWW.ecm.farmacovigilanza.org: An Italian website for CME in pharmacovigilance 61
Effects of some AMPA receptor antagonists on the development of tolerance in epilepsy-prone rats and in pentylenetetrazole kindled rats 61
Role of 5-lipoxygenase in the multiple organ failure induced by zymosan 61
Role of interleukin-6 in splanchnic artery occlusion shock. 60
Reversible orofacial dyskinesia after ofloxacin treatment 58
Molecular requirement for anticonvulsant activity in a series of thiazolo-1,4-benzodiazepine derivatives and comparison with classical benzodiazepines. 58
The charta of milan: basic criteria for the appropriate and accurate use of antibiotics: recommendations of the italian society of chemotherapy. 58
Inducibile nitric oxide synthase knock out mice exhibit resistance to pleurisy lung injury caused by carrageenan 56
Relationship between anticonvulsant activity and plasma level of some 2,3-benzodiazepines in genetically epilepsy-prone rats 56
Synthesis and anticonvulsant activity of novel non competitive as AMPA receptor antagonists. 54
Seizure susceptibility to various convulsant stimuli of knockout interleukin-6 mice 51
Interleukin-6 knock out mice exhibit a resistance to splanchnic artery occlusion shock 51
Effects of novel-6-desfluoroquinolones and classic quinolones on Pentylenetenazole induced seijures in mice 51
THALIDOMIDE TREATMENT REDUCES COLON INJURY INDUCED BY EXPERIMENTAL COLITIS 51
INHIBITORS OF POLY(ADP-RIBOSE) POLYMERASE MODULATE SIGNAL TRANSDUCTION PATHWAYS AND SECONDARY DAMAGE IN EXPERIMENTAL SPINAL CORD TRAUMA. 51
Gabapentin potentiates the antiseizure activity of certain anticonvulsants in DBA/2 mice 50
Role of interleukin-6 in a non-septic shock model induced by zymosan 50
Totale 8.432
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.674
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.674
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021484 0 0 0 0 0 93 2 101 0 72 65 151
2021/2022630 11 79 16 11 24 0 40 28 6 66 156 193
2022/20231.704 146 106 52 139 161 191 21 131 659 11 70 17
2023/2024466 52 70 27 108 25 84 12 47 1 16 4 20
2024/20251.750 20 18 58 113 101 35 9 477 449 59 111 300
2025/20261.717 161 303 455 310 423 65 0 0 0 0 0 0
Totale 8.570